← Leaderboards
Peter J Tonge
State University New York Stony Brook
$15,845,457
Attributed
$17,231,644
Total exposure
15
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,231,644 · 15
By mechanism
R01$7,872,314 · 5
U01$3,365,145 · 1
T32$2,772,375 · 2
R21$1,594,966 · 4
R35$1,176,072 · 1
R41$450,772 · 2
Top collaborators
- Nicole S. Sampson10 shared
- Elizabeth M Boon3 shared
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoEnzymesMycobacterium TuberculosisInfectionAnti-Bacterial AgentsDrug DiscoveryInhibitor/AntagonistDrug KineticsIn VitroPathogenLifeAntibioticsCellsBiologyDesignStructureAnimal ModelBaseBacteriaCoupledLeadDrug TargetingAffinityKinetics
Grant awards (61)
Mechanism of Slow Onset Enzyme Inhibition and Translation to Time-Dependent Drug Activity$392,024
R35 · FY2025 · GM · contact PI
Mechanism of Slow Onset Enzyme Inhibition and Translation to Time-Dependent Drug Activity$392,024
R35 · FY2024 · GM · contact PI
Mechanism of Slow Onset Enzyme Inhibition and Translation to Time-Dependent Drug Activity$392,024
R35 · FY2023 · GM · contact PI
Chemical Biology Training Interface$377,889
T32 · FY2022 · GM
Chemical Biology Training Interface$351,703
T32 · FY2021 · GM
Novel PET Radiotracers for Imaging Infection$343,139
R01 · FY2021 · EB · contact PI
Mechanism of Slow Onset Enzyme Inhibition and Translation to Time-Dependent Drug Activity$326,975
R01 · FY2021 · GM · contact PI
Novel PET Radiotracers for Imaging Infection$350,142
R01 · FY2020 · EB · contact PI
Mechanism of Slow Onset Enzyme Inhibition and Translation to Time-Dependent Drug Activity$326,975
R01 · FY2020 · GM · contact PI
Chemical Biology Training Interface$303,839
T32 · FY2020 · GM
A PET Diagnostic for Imaging Bacterial Infection$221,273
R41 · FY2020 · EB · contact PI
Novel PET Radiotracers for Imaging Infection$350,142
R01 · FY2019 · EB · contact PI
Mechanism of Slow Onset Enzyme Inhibition and Translation to Time-Dependent Drug Activity$326,975
R01 · FY2019 · GM · contact PI
SBU Chemistry-Biology Interface Training Program$244,943
T32 · FY2019 · GM
Evaluation of a Novel Infection PET Diagnostic$4,500
R41 · FY2019 · EB · contact PI
Novel PET Radiotracers for Imaging Infection$350,142
R01 · FY2018 · EB · contact PI
Mechanism of Slow Onset Enzyme Inhibition and Translation to Time-Dependent Drug Activity$326,719
R01 · FY2018 · GM · contact PI
SBU Chemistry-Biology Interface Training Program$281,273
T32 · FY2018 · GM
Evaluation of a Novel Infection PET Diagnostic$224,999
R41 · FY2018 · EB · contact PI
Administrative Supplement to GM102864, Funds for a Fluorimeter$156,843
R01 · FY2018 · GM · contact PI
SBU Chemistry-Biology Interface Training Program$198,318
T32 · FY2017 · GM
Novel Inhibitors of DNA Ligase LigA by Substrate-Assisted Tethered Inhibition$212,722
R21 · FY2016 · AI · contact PI
SBU Chemistry-Biology Interface Training Program$195,790
T32 · FY2016 · GM
Mechanism of Slow Onset Enzyme Inhibition and Drug Target Residence Time$292,815
R01 · FY2015 · GM · contact PI
Novel Inhibitors of DNA Ligase LigA by Substrate-Assisted Tethered Inhibition$212,062
R21 · FY2015 · AI · contact PI
SBU Chemistry-Biology Interface Training Program$193,326
T32 · FY2015 · GM
Mechanism of Slow Onset Enzyme Inhibition and Drug Target Residence Time$292,815
R01 · FY2014 · GM · contact PI
SBU Chemistry-Biology Interface Training Program$136,879
T32 · FY2014 · GM
Mechanism of Slow Onset Enzyme Inhibition and Drug Target Residence Time$281,854
R01 · FY2013 · GM · contact PI
SBU Chemistry-Biology Interface Training Program$140,606
T32 · FY2013 · GM
Mechanism of Slow Onset Enzyme Inhibition and Drug Target Residence Time$291,191
R01 · FY2012 · GM · contact PI
SBU Chemistry-Biology Interface Training Program$140,606
T32 · FY2012 · GM
SBU Chemistry-Biology Interface Training Program$138,740
T32 · FY2011 · GM
Chemotherapeutics Against Multi-Drug Resistant Tuberculosis$767,263
U01 · FY2010 · AI · contact PI
Using PET isotopes to identify drug targets and to diagnose infectious diseases$249,895
R21 · FY2010 · AI · contact PI
SBU Chemistry-Biology Interface Training Program$68,463
T32 · FY2010 · GM
Chemotherapeutics Against Multi-Drug Resistant Tuberculosis$854,641
U01 · FY2009 · AI · contact PI
Targetting InhA For Anti-TB Drug Discovery$257,195
R01 · FY2009 · AI · contact PI
Using PET isotopes to identify drug targets and to diagnose infectious diseases$210,399
R21 · FY2009 · AI · contact PI
Targetting InhA For Anti-TB Drug Discovery$67,295
R01 · FY2009 · AI · contact PI
Chemotherapeutics Against Multi-Drug Resistant Tuberculosis$615,510
U01 · FY2008 · AI · contact PI
Targetting InhA For Anti-TB Drug Discovery$205,756
R01 · FY2008 · AI · contact PI
Chemotherapeutics Against Multi-Drug Resistant Tuberculosis$527,730
U01 · FY2007 · AI · contact PI
Targetting InhA For Anti-TB Drug Discovery$249,602
R01 · FY2007 · AI · contact PI
Structure-Function Studies of Fluorescent Proteins$236,884
R01 · FY2007 · GM · contact PI
Chemotherapeutics Against Multi-Drug Resistant Tuberculosis$600,001
U01 · FY2006 · AI · contact PI
Structure-Function Studies of Fluorescent Proteins$243,959
R01 · FY2006 · GM · contact PI
Targetting InhA For Anti-TB Drug Discovery$236,122
R01 · FY2006 · AI · contact PI
Targetting InhA For Anti-TB Drug Discovery$253,625
R01 · FY2005 · AI
Structure-Function Studies of Fluorescent Proteins$249,830
R01 · FY2005 · GM
Menaquinone Biosynthesis in M. Tuberculosis$230,063
R21 · FY2005 · AI
Structure-Function Studies of Fluorescent Proteins$291,330
R01 · FY2004 · GM
Menaquinone Biosynthesis in M. Tuberculosis$227,813
R21 · FY2004 · AI
Substrate Recognition and Activation in Beta-Oxidation$218,601
R01 · FY2004 · GM
Inhibition of Fatty Acid Biosynthesis in M. Tuberculosis$252,012
R21 · FY2003 · AI
Substrate Recognition and Activation in Beta-Oxidation$218,601
R01 · FY2003 · GM
Substrate Recognition and Activation in Beta-Oxidation$218,601
R01 · FY2002 · GM
RATIONAL INHIBITION OF INHA, A TUBERCULOSIS DRUG TARGET$203,168
R01 · FY2002 · AI
RATIONAL INHIBITION OF INHA, A TUBERCULOSIS DRUG TARGET$274,165
R01 · FY2001 · AI
Substrate Recognition and Activation in Beta-Oxidation$239,351
R01 · FY2001 · GM
RATIONAL INHIBITION OF INHA, A TUBERCULOSIS DRUG TARGET$191,502
R01 · FY2000 · AI